Poor formulary communication costs health systems money in ways that rarely show up as a single line item, which is exactly why the problem persists as long as it does.

Daniel Robertson Honored for Two Decades of Technical Leadership Behind Rpharmy’s Healthcare Compliance Products

If you work in oncology or infusion, you already know that biosimilars aren't coming; they're here. For most drugs, your team has figured out the clinical piece. You know the science, you understand interchangeability, and you've read the FDA approvals.

The part that keeps tripping people up isn't clinical. It's communication.

And like I said at the Health Connect Partners event in May (to a room full of chuckles), formulary excites me. 😀 If you don’t believe me, here’s proof...

We're Having a "Make It Make Sense" Moment.

Audit Demonstrates Rpharmy's Dedication to Protecting Sensitive Customer Data

What are you doing to protect employees from hazardous drug exposure who don’t have access to the EHR?

How Can We Transform Outpatient Pharmacy Safety Through Data, Culture, and Accountability? 

In this installment of our Healthcare Affirmations series, we're spotlighting Audrey Kostrzewa, PharmD, MPH, Professor of Pharmacy Practice and Medication Utilization Pharmacist, whose dual role in academia and health systems bridges the gap between teaching the next generation and tackling one of pharmacy's most pressing challenges: systematic safety in outpatient settings.

Last year at this time, we were reflecting on one year of USP <800> enforcement. Little did we know that NIOSH would release an updated list of hazardous drugs and also a new format consisting of two main tables. Welcome to 2025!

Austin-Based Healthcare Technology Provider Recognized for Community Impact, Life-Saving Solutions that Protect Patients, Healthcare Workers